JSJ.P.M. Sedelaar

J.P.M. Sedelaar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


J.P.M. Sedelaar has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • C.A. Hulsbergen‐Van der Kaa

    Department of Pathology, University Medical Center St Radboud, Nijmegen, The Netherlands

    1 shared publication
  • G.J.L.H. van Leenders

    Department of Pathology, University Medical Center St Radboud, Nijmegen, The Netherlands

    1 shared publication
  • H. Wijkstra

    Department of Urology, University Medical Center St Radboud, Nijmegen, The Netherlands

    1 shared publication
  • J.J.M.C.H. de la Rosette

    Department of Urology, University Medical Center St Radboud, Nijmegen, The Netherlands

    1 shared publication
  • N.P. van Adrichem

    Department of Urology, De Eemland Ziekenhuis, Amersfoort, The Netherlands

    1 shared publication
  • T.E.B. Goossen

    Department of Pathology, University Medical Center St Radboud, Nijmegen, The Netherlands

    1 shared publication

Latest Publications

  • Value of contrast ultrasonography in the detection of significant prostate cancer: Correlation with radical prostatectomy specimens

    by J.P.M. Sedelaar, G.J.L.H. van Leenders, T.E.B. Goossen, C.A. Hulsbergen‐Van der Kaa, N.P. van Adrichem, H. Wijkstra, J.J.M.C.H. de la Rosette

    BACKGROUND: The presented study has investigated a possible improvement of imaging prostate cancer: three‐dimensional contrast‐enhanced power Doppler ultrasonography (3D‐CE‐PDU).METHODS: Seventy patients with biopsy proven prostate cancer and scheduled for radical retropubic prostatectomy received a 3D‐CE‐PDU investigation before surgery. Two experts analyzed the ultrasound images. The ultrasound images were correlated to the whole‐mount sections of the prostate specimen. The correlation protocol consisted of three evaluation steps.RESULTS: In total, 153 prostate tumors were found in the 70 prostate specimens: 61 tumors <5 mm, 93 tumors ≥5 mm. The diagnosis of clinical significant and insignificant prostate cancer was made in 85 and 88% of the patients for expert I and II, respectively. Diagnosis by imaging improved from 61% (43 of 70 of the prostate cancers) for standard detection tools to an average 86% (60 of 70 prostate cancers) for 3D‐CE‐PDU.CONCLUSION: 3D‐CE‐PDU improves the detection of prostate cancer in this group of prostate cancer patients. The use of 3D‐CE‐PDU in the clinic is questionable as indications are still unclear. Prostate 53: 246–253, 2002.